SLRN Total Utang marang Modal ACELYRIN Inc.

Acelyrin, Inc. (SLRN) develops specialized treatments for severe inflammatory processes, including psoriasis, targeting patients at oncology centers. This historical price chart shows a total debt-to-equity ratio of 0.01. The firm's results depend on medical breakthroughs rather than macroeconomics. The company is currently scaling its innovative portfolio, focusing on final trials of drugs for the therapy of rare skin and eye diseases.

SLRN: Total Utang marang Modal ACELYRIN 21.02.2024 - 31.05.2025

Rincian analitis lan laporan data perusahaan ACELYRIN Inc. (SLRN)

- rega lan prakiraan konsensus rega:
Bagan rega ACELYRIN|SLRN - Bagan tingkat prakiraan
- data kapitalisasi pasar:
Kapitalisasi pasar ACELYRIN|SLRN - Nilai Dipunlarasaken Utang lan Kas
- data kapitalisasi buku:
Nilai Buku saben Saham ACELYRIN|SLRN - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku acelyrin.com|SLRN - Nilai Agregat Aset
- data utang lan likuiditas:
Utang marang Ekuitas Acelyrin, Inc.|SLRN - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Acelyrin, Inc.|SLRN - Gunggung utang perusahaan|Utang marang nilai buku ACELYRIN|SLRN - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan ACELYRIN
Analisis komprehensif perusahaan:SLRN - ACELYRIN

This ratio measures the degree of financial leverage by comparing total liabilities to net assets to assess the business's dependence on borrowed funds. For Acelyrin, Inc. (SLRN), whose success depends on clinical immunotherapy data, the debt-to-equity ratio history reflects the cost of capital during periods of volatility, determining the funding stability of research and development regardless of macroeconomic cycles.

Pesaing wigati

Utang marang Ekuitas Haleon HLN|Utang Agregat marang Ekuitas Kenvue Inc|Verona Pharma Corp (VRNA) - Total Utang marang Modal|Rasio Kabeh Utang marang Dana Pribadi Jyong Bio (MENS)|Total Utang marang Modal LGND (Ligand Pharmaceuticals)|amneal.com - Total Utang marang Modal|Utang marang Ekuitas Perrigo (PRGO)|ALVO: Rasio Kabeh Utang marang Dana Pribadi|LQDA (Liquidia Technologies) - Utang marang Ekuitas|Galapagos Corp (GLPG) - Rasio Total Utang marang Ekuitas|ANIP (ANI Pharmaceuticals) - Total Utang marang Modal|Total Utang marang Modal mannkindcorp.com (MNKD)|Amphastar Pharmaceuticals, Inc. (AMPH) - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi PCRX (Pacira Pharmaceuticals)|SPRY: Utang marang Ekuitas|TBPH - Utang marang Modal|Rasio Total Utang marang Ekuitas Aquestive Therapeutics AQST|SCPH - Utang Agregat marang Modal|Total Utang marang Modal tectonictx.com TECX|Tonix Pharma (TNXP) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal SXTC (SXT Pharmaceuticals)|Utang marang Modal EPRX|BioHarvest Sciences (BHST) - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi invizyne.com (EXOZ)|Total Utang marang Modal ORMP (Oramed Pharmaceuticals Inc.)|Total Utang marang Modal Entera Bio Ltd ENTX|HYFT: Total Utang marang Modal|ABVC - Rasio Total Utang marang Ekuitas|Total Utang marang Modal CPIX|QNTM (quantumbiopharma.com) - Utang marang Modal|Utang marang Ekuitas FibroGen|Utang marang Ekuitas Telomir Pharmaceuticals Inc (TELO)|Rani Therapeutics - Rasio Total Utang marang Ekuitas|Utang marang Modal SNYR (synergychc.com)|Utang marang Ekuitas Rallybio|Rasio Kabeh Utang marang Dana Pribadi Lexaria Bioscience Corp LEXX|Total Utang marang Modal PULM (Pulmatrix)|PTHL: Koefisien Total Utang marang Modal|Utang marang Ekuitas aptorumgroup.com|Rasio Utang marang Ekuitas Lyra Therapeutics Inc|IBO - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi TNF Pharma|YCBD (cbdMD, Inc.) - Total Utang marang Modal|Koefisien Total Utang marang Modal PRFX (PainReform Ltd)|CYTO - Utang marang Ekuitas|Rasio Utang marang Ekuitas Lipella Pharma LIPO|OPTN: Total Utang marang Modal|pieris.com (PIRS) - Rasio Total Utang marang Ekuitas|Procaps - Rasio Total Utang marang Ekuitas|PTPI (Petros Pharmaceuticals Inc) - Koefisien Total Utang marang Modal|QLI: Utang marang Ekuitas|Koefisien Total Utang marang Modal TFFP